Travere Therapeutics Inc.

20.96
0.83 (4.12%)
At close: Jan 28, 2025, 1:56 PM

Travere Therapeutics Inc. Forecast

Stock Price Forecast

The 12 analysts with 12-month price forecasts for TVTX stock have an median target of 22, with a low estimate of 19 and a high estimate of 27. The median target predicts an increase of 4.96% from the current stock price of 20.96.

Analyst Consensus: Buy
Target Low Average Median High
Price $19 $22.7 $22 $27
Change -9.35% 8.30% 4.96% 28.82%

AI Analyst Report

HC Wainwright & Co. has reiterated a Buy rating on... Unlock content with Pro Subscription

Updated Jan 15, 2025

Rating May 24Aug 24Sep 24Oct 24Nov 24Jan 25
Strong Buy 114201
Buy 137620
Hold 010010
Sell 000000
Strong Sell 000000
Total 2 5 11 8 3 1

Financial Forecast this Year

Revenue This Year
230.58M
from 145.24M
Increased by 58.8%
Revenue Next Year
342.48M
from 230.58M
Increased by 48.5%
EPS This Year
-3.66
from -1.5
Increased by -144%
EPS Next Year
-1.13
from -3.66
Increased by 69.1%